Molecular and Cellular Endocrinology 214 (2004) 149–153
Pdcd4 inhibits growth of tumor cells by suppression
of carbonic anhydrase type II
B. Lankat-Buttgereit
a
, C. Gregel
a
, A. Knolle
b
, A. Hasilik
c
, R. Arnold
a
, R. Göke
a,∗
a
Clinical Research Unit for Gastrointestinal Endocrinology, University of Marburg, Baldingerstrasse, 35033 Marburg, Germany
b
Department of Pathology and Laboratory Medicine, School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
c
Institute of Physiological Chemistry, University of Marburg, Baldingerstrasse, 35033 Marburg, Germany
Received 19 August 2003; accepted 22 October 2003
Abstract
To identify new genes that are upregulated during apoptosis we previously cloned rat pdcd4. While the role of pdcd4 is still unclear it seems
to possess a tumor suppressor activity. Pdcd4 directly interacts with the RNA helicase eIF4A and inhibits protein synthesis by interfering with
the assembly of the cap-dependent translation initiation complex. In the present study, we show that pdcd4 suppresses carbonic anhydrase
type II protein expression in HEK293 and Bon-1 carcinoid cells. Since tumor cells require a high bicarbonate flux for their growth, carbonic
anhydrase suppression results in growth inhibition. Similar to pdcd4, carbonic anhydrase inhibitor ethoxyzolamide reduces growth of several
endocrine tumor cell lines. Thus, the translation inhibitor pdcd4 represses endocrine tumor cell growth by suppression of carbonic anhydase
II. Furthermore, carbonic anhydrase inhibitors might represent promising tools for anti-endocrine tumor treatment.
© 2003 Elsevier Ireland Ltd. All rights reserved.
Keywords: Pdcd4; Carbonic anhydrase; Endocrine tumor; Ethoxyzolamide; Translation
1. Introduction
Programmed cell death, also termed apoptosis, plays a
fundamental role in many biological processes as embryo-
genesis, normal tissue turnover and immune homeostasis
(Saikumar et al., 1999; Evan and Littlewood, 1998; Thorn-
berry and Lazebnik, 1998; Ashkenazi and Dixit, 1998).
Although to date a number of caspase-dependent and in-
dependent apoptotic pathways have been identified, the
mechanisms of cell death are very complex and are still
largely unknown. In an attempt to identify genes which are
involved in the regulation of apoptosis we cloned rat pdcd4
(death upregulated gene; DUG) (Göke et al., 2002). Pdcd4 is
constitutively expressed at low levels in normal cells but is
upregulated after induction of apoptosis by different stimuli
like death ligands and serum/glucose starvation. Pdcd4 is
highly conserved during evolution indicating an important
biological function of this protein. Analysis of the amino
acid sequence revealed the presence of two conserved
∗
Corresponding author. Tel.: +49-6421-2862714;
fax: +49-6421-2868924.
E-mail address: rgoeke@gmx.net (R. Göke).
-helical MA3 domains, which are known to be involved in
protein–protein interactions. The eukaryotic translation ini-
tiation factor 4G interacts with the RNA helicase eIF4A via
the MA3 domain (Ponting, 2000). eIF4A which is part of the
cap-dependent translation initiation complex unwinds the
mRNA allowing the ribosome to scan along the mRNA to
locate the initiating AUG codon. Recently, we showed that
pdcd4 like eIF4G interacts with eIF4A (Göke et al., 2002).
Our assumption that pdcd4 inhibits translation by direct
interaction with eIF4A was confirmed by Yang et al., 2003.
Carbonic anhydrase catalyzes the hydration of CO
2
to
bicarbonate. Bicarbonate is an important substrate for many
fundamental biological pathways as gluconeogenesis, li-
pogenesis, ureagenesis, pyrimidine synthesis and synthesis
of several amino acids (Chegwidden et al., 2000). Can-
cer cells have a higher replication rate than normal cells
requiring a high flux of bicarbonate into these metabolic
pathways. Therefore, providing bicarbonate as substrate,
carbonic anhydrase isoforms seem to play an important role
for tumor cell growth. In accordance with this assumption,
it was reported that expression of carbonic anhydrase I
and II correlated with aggessiveness of colorectal cancer
and synchronous distant metastasis (Bekku et al., 2000).
0303-7207/$ – see front matter © 2003 Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.mce.2003.10.058